Annual report pursuant to Section 13 and 15(d)

Earnings Per Share (Tables)

v3.22.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share

Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:

(in thousands, except per share data)

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Numerator

 

 

 

 

 

 

 

 

 

Net increase (decrease) in net assets resulting from operations

 

$

102,081

 

 

$

174,155

 

 

$

227,261

 

Less: Total distributions declared

 

 

(249,077

)

 

 

(179,575

)

 

 

(155,761

)

Total Earnings, net of total distributions

 

 

(146,996

)

 

 

(5,420

)

 

 

71,500

 

 

 

 

 

 

 

 

 

 

 

Earnings, net of distributions attributable to common shares

 

 

(146,995

)

 

 

(5,420

)

 

 

70,995

 

Add: Distributions declared attributable to common shares

 

 

246,873

 

 

 

177,864

 

 

 

154,658

 

Numerator for basic and diluted change in net assets per common share

 

$

99,878

 

 

$

172,444

 

 

$

225,653

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

125,189

 

 

 

114,742

 

 

 

111,985

 

Incremental shares from assumed conversion of 2022 Convertible Notes

 

 

 

 

 

512

 

 

 

 

Common shares issuable

 

 

1,470

 

 

 

701

 

 

 

282

 

Weighted average common shares outstanding assuming dilution

 

 

126,659

 

 

 

115,955

 

 

 

112,267

 

 

 

 

 

 

 

 

 

 

 

Change in net assets per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.80

 

 

$

1.50

 

 

$

2.02

 

Diluted

 

$

0.79

 

 

$

1.49

 

 

$

2.01

 

Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock For the years ended December 31, 2022, 2021 and 2020, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:

 

 

Year Ended December 31,

 

Anti-dilutive Securities

 

2022

 

 

2021

 

 

2020

 

2022 Convertible Notes

 

 

 

 

 

 

 

 

5,543,097

 

Unvested common stock options

 

 

2,085

 

 

 

690

 

 

 

66,578

 

Restricted stock units*

 

 

 

 

 

20

 

 

 

 

Unvested restricted stock awards

 

 

2,116

 

 

 

861

 

 

 

10,049

 

Performance awards*